A high incidence of C9 deficiency among healthy blood donors in Osaka, Japan

International Immunology
Y FukumoriS Inai

Abstract

By the use of sucrose gelatin veronal buffer (SGVB), a simple screening test was developed by us to detect sera with low complement activity, including C9-deficient sera. Using this screening test, we were able to identify sera with low complement activity including C9-deficient sera among a large number of samples. Further examinations, estimation of the protein concentration of C9, C4, C3, etc., enabled classification of serum with low complement activity into C9-deficient serum, serum deficient in the other components, and serum with low complement activity caused by non-specific activation of complement through the classical pathway by low temperature in vitro. Among 145,640 sera from Osaka donors, 138 sera were found to be deficient in C9 by these methods. The whole complement activity (CH50) of the 138 sera was 13.1 +/- 3.0 U/ml. The C9 protein in these sera was undetectable, not only by the single radial immunodiffusion method, but also by the sensitive ELISA method. C9 activities in these sera were less than 0.1% of the level in pooled normal human serum. These findings and the family studies revealed that 138 blood donors unquestionably had a hereditary C9 deficiency. The incidence of C9 deficiency among Osaka donors w...Continue Reading

Citations

Dec 1, 1995·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·K MaruyamaA Morikawa
Jan 13, 2000·Clinical and Experimental Immunology·Z ZhuJ E Volanakis
Dec 1, 1991·The Journal of Experimental Medicine·K HorikawaK Takatsuki
Jun 1, 1996·European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics·S GonzalezC López-Larrea
Oct 12, 2010·Clinical Microbiology Reviews·Sanjay RamPeter A Rice
Nov 1, 1992·Kidney International·K YoshiokaY Takekoshi
Oct 20, 1998·Immunobiology·M J WalportM Botto
Jun 1, 2011·Molecular Immunology·Lillemor SkattumLennart Truedsson
Apr 22, 2004·The Journal of Allergy and Clinical Immunology·Leana WenPatricia C Giclas
Nov 14, 2015·Journal of Clinical Immunology·Sagar BhattadSurjit Singh
Jul 20, 2014·Molecular Immunology·Anete Sevciovic Grumach, Michael Kirschfink
Oct 26, 2013·Autoimmunity Reviews·Karmtej SinghM Eric Gershwin
Apr 4, 2017·The Journal of Infectious Diseases·Jérémie RosainVéronique Frémeaux-Bacchi
Sep 1, 1991·Immunology Today·B P Morgan, M J Walport
Jan 1, 1995·Critical Reviews in Clinical Laboratory Sciences·B P Morgan
Nov 13, 1998·Arteriosclerosis, Thrombosis, and Vascular Biology·W SchmiedtS Bhakdi
Apr 5, 1997·Annals of the New York Academy of Sciences·M J WalportM Botto
Sep 10, 2020·Antibodies·Ronald P Taylor, Margaret A Lindorfer
Apr 28, 2018·Molecular Diagnosis & Therapy·Laura Lorés-MottaAnneke I den Hollander
Nov 27, 2019·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Rachele M Hendricks-Sturrup, Christine Y Lu
Feb 22, 2003·Human Genetics·Vahid KhajoeeToshiro Hara
Mar 26, 2003·Clinical and Experimental Immunology·M A Dragon-DureyM D Kazatchkine
Mar 11, 2021·Pharmacological Reviews·Peter GarredTom E Mollnes

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.